Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker seeks to expand its immunology pipeline.
from Reuters: Business News https://ift.tt/2HR4ibc
Stay Updated with Latest Business News and Views from All Corners of the World.
Subscribe to:
Post Comments (Atom)
Mark Zuckerberg unveils his latest persona: Elon Musk
Toby Melville/Pool Photo via AP; BRENDAN SMIALOWSKI/AFP via Getty Images; Chelsea Jia Feng/BI While Mark Zuckerberg and Elon Musk nev...
-
Before investing your own money into a small business idea, test it out with your target audience. Georgijevic/Getty Images Having a bu...
-
Omnicom CEO John Wren. Emmanuel Dunand/AFP via Getty Images Ad industry insiders say the Omnicom takeover of Interpublic Group could ki...
-
Krisanapong Detraphiphat/Getty Images; Jenny Change-Rodriguez/BI Illustration Goldman Sachs forecasts muted S&P 500 gains, with a ...
No comments:
Post a Comment